Search
for
Sort by
Research 31–60 of 398
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Advances in the mechanism and new therapies of alopecia areata
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor
- Control of pelage hair follicle development and cycling by complex interactions between follistatin and activin
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Ritlecitinib: First Approval
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Transcriptome and proteome characterization of surface ectoderm cells differentiated from human iPSCs
- Hair Follicle Reconstruction and Stem Cells
- Pharmacotherapy of alopecia areata
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- DKK1 Mediated Inhibition of Wnt Signaling in Postnatal Mice Leads to Loss of TEC Progenitors and Thymic Degeneration
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results